What to Know About the COVID-19 Vaccine Dosing Debate
Faced with limited COVID-19 vaccine doses and the ever-mounting toll of the pandemic, a new debate has emerged as to the best strategy for allocation.

Faced with limited COVID-19 vaccine doses and the ever-mounting toll of the pandemic, a new debate has emerged as to the best strategy for allocation.
If COVID-19 vaccines lead to any serious harms, society should compensate those victims generously and quickly.
Professor Glenn Cohen, one of the world’s leading experts on the intersection of bioethics and law, to discusses covid vaccine distribution.
We can simultaneously get COVID vaccines to those most at risk while minimizing harm to our ability to fully evaluate their safety and efficacy.
Paying for vaccination is dubious public health policy likely to backfire in terms of (re)building public trust in vaccines.
Can private businesses mandate that employees and customers receive COVID-19 vaccines authorized for emergency use?
In the past weeks, three companies in advanced stages of COVID-19 vaccine trials reported good news. What does this mean?